90 related articles for article (PubMed ID: 16180251)
1. Distinct effects of CD86-mediated costimulation on resting versus activated human CD4+ T cells.
Rogers NJ; Game DS; Camara NO; Jackson IM; Lombardi G; Lechler RI
Eur J Immunol; 2005 Oct; 35(10):2909-19. PubMed ID: 16180251
[TBL] [Abstract][Full Text] [Related]
2. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
3. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
4. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE
J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593
[TBL] [Abstract][Full Text] [Related]
5. CD40 can costimulate human memory T cells and favors IL-10 secretion.
Rogers NJ; Jackson IM; Jordan WJ; Lombardi G; Delikouras A; Lechler RI
Eur J Immunol; 2003 Apr; 33(4):1094-104. PubMed ID: 12672076
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
Mukherjee S; Ahmed A; Malu S; Nandi D
J Leukoc Biol; 2006 Jul; 80(1):66-74. PubMed ID: 16624934
[TBL] [Abstract][Full Text] [Related]
7. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
8. Cross-species costimulation: relative contributions of CD80, CD86, and CD40.
Rogers NJ; Jackson IM; Jordan WJ; Hawadle MA; Dorling A; Lechler RI
Transplantation; 2003 Jun; 75(12):2068-76. PubMed ID: 12829914
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
10. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
[TBL] [Abstract][Full Text] [Related]
11. Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.
Manzotti CN; Liu MK; Burke F; Dussably L; Zheng Y; Sansom DM
Eur J Immunol; 2006 Jun; 36(6):1413-22. PubMed ID: 16708397
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
[TBL] [Abstract][Full Text] [Related]
13. CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHA.
Vasilevko V; Ghochikyan A; Holterman MJ; Agadjanyan MG
DNA Cell Biol; 2002 Mar; 21(3):137-49. PubMed ID: 12015893
[TBL] [Abstract][Full Text] [Related]
14. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
[TBL] [Abstract][Full Text] [Related]
15. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
Habib-Agahi M; Jaberipour M; Phan TT; Searle PF
Iran J Immunol; 2008 Sep; 5(3):136-47. PubMed ID: 18791280
[TBL] [Abstract][Full Text] [Related]
16. 4-1BBL costimulation retrieves CD28 expression in activated T cells.
Habib-Agahi M; Jaberipour M; Searle PF
Cell Immunol; 2009; 256(1-2):39-46. PubMed ID: 19217084
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
[TBL] [Abstract][Full Text] [Related]
18. B7+CTLA4+ T cells engage in T-T cell interactions that mediate apoptosis: a model for lentivirus-induced T cell depletion.
Vahlenkamp TW; Bull ME; Dow JL; Collisson EW; Winslow BJ; Phadke AP; Tompkins WA; Tompkins MB
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):203-14. PubMed ID: 15010229
[TBL] [Abstract][Full Text] [Related]
19. Two regions in the CD80 cytoplasmic tail regulate CD80 redistribution and T cell costimulation.
Doty RT; Clark EA
J Immunol; 1998 Sep; 161(6):2700-7. PubMed ID: 9743326
[TBL] [Abstract][Full Text] [Related]
20. Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation.
Tsukahara R; Takeuchi M; Akiba H; Kezuka T; Takeda K; Usui Y; Usui M; Yagita H; Okumura K
Int Immunol; 2005 May; 17(5):523-30. PubMed ID: 15778288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
